Accession Number:

ADD018396

Title:

Antisense Oligonucleotides Directed Against Human VCAM-1 RNA.

Descriptive Note:

Patent, Filed 12 Oct 93, patented 21 Jan 97,

Corporate Author:

DEPARTMENT OF THE NAVY WASHINGTON DC

Report Date:

1997-01-21

Pagination or Media Count:

18.0

Abstract:

Antisense oligonucleotides complementary to human mRNAs or pre-mRNAs coding for VCAM-1 are used in a therapeutic treatment of sepsis sepsis, the sepsis syndrome, sepsis shock and all other manifestations of the sepsis disease, including but not inclusive of, adult respiratory distress syndrome, multi-organ failure, or cardiovascular dysfunction.

Subject Categories:

  • Medicine and Medical Research
  • Toxicology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE